TARA: Protara Analyst Consensus Forecast

Symbol and logo of brand Protara Therapeutics Inc (TARA)

Protara Therapeutics (TARA) is implementing AI control and closed bioreactors to automate drug synthesis, minimizing manual labor. The humanitarian profile of the business shields its developments from sanctions and geopolitical risks. This price chart demonstrates a consensus forecast of 25.22. Meanwhile, the financial position relies on investments and R&D success, as the company does not yet have regular sales revenue.

TARA: Protara Therapeutics Analyst Consensus Forecast 07/04/2022 - 11/11/2026

Analytical breakdowns for Protara (TARA)

- stock quotes and analyst forecast:
Price protaratx.com|TARA - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Protara|TARA - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Protara Therapeutics|TARA - Book Capitalization|Market Capitalization to Book Value Ratio protaratx.com|TARA - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Protara Therapeutics|TARA - Long-Term Debt to Capital|Short-Term Debt to Capital Protara Tx|TARA - Company Debts|Debt to Book Value Ratio Protara|TARA - Company Long-Term Debts|Company Current Liabilities Protara Therapeutics|Immediate Liquidity protaratx.com
- earnings and valuation multiples information:
TARA - Company Net Income|Expected Net Income Protara Therapeutics|TARA - Price to Earnings Ratio|Future Price to Earnings Multiple Protara Therapeutics Inc|TARA - PEG Multiple|Enterprise Value to EBITDA Ratio Protara|TARA - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Protara Therapeutics|TARA - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months protaratx.com|TARA - Earnings growth in current year|Expected net earnings per share growth next year Protara Therapeutics
Fundamental company analysis:protaratx.com (TARA)
Original product of Protara

Strategic alliances between Protara Therapeutics (TARA) and research centers are accelerating the commercialization of bio-assets, directly impacting market expectations regarding business valuation. The trajectory of analysts' target prices aggregates average expert forecasts for the stock's fair value, allowing investors to gauge market confidence in the company's capital through the dynamics of the fundamental revaluation of its prospects.

Competing companies

Analyst Forecast Prices ONC|Analyst Consensus Forecast HALO (Halozyme)|Analyst Consensus Forecast Revolution Medicines Inc RVMD|AAPG - Price Target Chart|Fair Value Consensus CGON (CG Oncology Therapeutics)|URGN: Analyst Consensus Forecast|bicara.com (BCAX) - Analyst Consensus Forecast|PSNL (Personalis) - Analyst Consensus Forecast|Consensus Target Erasca Inc (ERAS)|Analyst Consensus Forecast DCTH|Analyst Consensus Forecast Y-mAbs Corp (YMAB)|Price Target Chart Aura Biosciences, Inc. AURA|CADL: Broker Consensus Forecast|Accuray - Analyst Consensus Forecast|SELLAS Life Sciences (SLS) - Consensus Target|ACTU: Analyst Consensus Forecast|Average Forecast Price Citius Oncology Inc (CTOR)|Price Target Chart TuHURA Biosciences Inc.|FATE: Fair Value Consensus|Consensus Target WHWK (Aadi Bioscience Inc)|TCRX (tscan.com) - Fair Value Consensus|Analyst Consensus Forecast CSBR (Champions Oncology, Inc.)|XBIT - Consensus Target|CVM: Consensus Target|OSTX - Analyst Consensus Forecast|Radiopharm Theranostics Limited (RADX) - Price Target Chart|Artiva Biotherapeutics - Fair Value Consensus|ANL (Adlai Nortye Ltd) - Analyst Consensus Forecast|Average Forecast Price Veru Corporation VERU|Price Target Chart Tempest Therapeutics (TPST)|XLO: Forecast Levels Chart|Price Target Chart Renovaro RENB|Fair Value Consensus MURA|KAPA - Price Target Chart|Average Forecast Price OnKure Therapeutics Inc|GDTC (w2.cytomed.sg) - Consensus Target|CRIS: Analyst Forecast Prices|APLM (Apollomics Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tharimmune Inc|Price Target Chart Advanced Biomed Inc (ADVB)|GNPX (Genprex Inc) - Fair Value Consensus|Analyst Consensus Forecast CLDI (Calidi Biotherapeutics, Inc.)|Analyst Consensus Forecast Sunshine Biopharma Inc. SBFM|XBIO: Consensus Target|Fair Value Consensus SLRX (Salarius Pharmaceuticals Inc)|PPBT (Purple Biotech Corp) - Consensus Target|AONC: Analyst Forecast Prices|BGNE (BeiGene, Ltd.) - Analyst Consensus Forecast|CKPT: Fair Value Consensus|Analyst Consensus Forecast ELEV|ICAD - Average Forecast Price|Price Target Chart Ikena Oncology IKNA|Fair Value Consensus NTBL|Viracta - Analyst Consensus Forecast|MOR - Analyst Consensus Forecast|NAYA Biosciences Inc. (NAYA) - Price Target Chart|Forecast Levels Chart AAPGV (Ascentage Pharma Group International)